Zimmer Biomet Holdings (ZBH) Reaches $118.67 After 9.00% Down Move, Synthesis Energy Systems (SYMX) Shorts Up By 3.55%

May 16, 2017 - By Adrian Mccoy

The stock of Zimmer Biomet Holdings Inc (NYSE:ZBH) is a huge mover today! About 2.49M shares traded or 83.09% up from the average. Zimmer Biomet Holdings Inc (NYSE:ZBH) has declined 7.29% since October 6, 2016 and is downtrending. It has underperformed by 17.94% the S&P500.The move comes after 5 months negative chart setup for the $24.14B company. It was reported on May, 16 by Barchart.com. We have $107.99 PT which if reached, will make NYSE:ZBH worth $2.17 billion less.

Synthesis Energy Systems Incorporated (NASDAQ:SYMX) had an increase of 3.55% in short interest. SYMX’s SI was 1.20M shares in May as released by FINRA. Its up 3.55% from 1.16M shares previously. With 77,000 avg volume, 16 days are for Synthesis Energy Systems Incorporated (NASDAQ:SYMX)’s short sellers to cover SYMX’s short positions. The SI to Synthesis Energy Systems Incorporated’s float is 1.91%. About 661,102 shares traded or 61.73% up from the average. Synthesis Energy Systems, Inc. (NASDAQ:SYMX) has declined 19.30% since October 6, 2016 and is downtrending. It has underperformed by 29.95% the S&P500.

Synthesis Energy Systems, Inc. is a clean energy firm that develops, manufactures and owns clean energy projects. The company has market cap of $62.09 million. The Firm owns gasification technology, which it utilizes to provide technology licenses and equipment to clients in the energy and chemical industries. It currently has negative earnings. The Firm operates through divisions, including SES China, Technology Licensing and Related Services, and Corporate.

Investors sentiment decreased to 1.11 in Q4 2016. Its down 0.46, from 1.57 in 2016Q3. It worsened, as 4 investors sold Synthesis Energy Systems, Inc. shares while 5 reduced holdings. 4 funds opened positions while 6 raised stakes. 23.15 million shares or 36.67% more from 16.94 million shares in 2016Q3 were reported. State Street Corporation reported 21,000 shares. Royal Fincl Bank Of Canada holds 300 shares. 194,900 were reported by Blackrock Fund. Blackrock Advisors Limited Liability Corp holds 5,951 shares. Raymond James Fincl holds 17,500 shares or 0% of its portfolio. Citadel Advsr Ltd Company accumulated 27,269 shares. Bancorporation Of Mellon invested in 45,217 shares or 0% of the stock. Blackrock Invest Mgmt Limited Liability holds 0% of its portfolio in Synthesis Energy Systems, Inc. (NASDAQ:SYMX) for 12,845 shares. National Asset Mgmt owns 320,650 shares. Comml Bank Of America De holds 100,000 shares. Kcg invested in 13,655 shares. California Employees Retirement Systems owns 149,999 shares. Tower Rech Cap Ltd Liability (Trc) holds 0% or 1,600 shares in its portfolio. Guggenheim Cap holds 0% or 20,610 shares in its portfolio. Manufacturers Life Ins The reported 606 shares stake.

Among 17 analysts covering Zimmer Biomet Holdings (NYSE:ZBH), 12 have Buy rating, 1 Sell and 4 Hold. Therefore 71% are positive. Zimmer Biomet Holdings had 30 analyst reports since August 27, 2015 according to SRatingsIntel. The stock of Zimmer Biomet Holdings Inc (NYSE:ZBH) earned “Market Perform” rating by Wells Fargo on Friday, April 28. Zacks downgraded the shares of ZBH in report on Friday, August 28 to “Buy” rating. The stock has “Neutral” rating by Guggenheim on Thursday, June 9. As per Thursday, January 26, the company rating was maintained by Needham. The stock has “Strong Buy” rating by Needham on Tuesday, November 1. The rating was maintained by Needham on Friday, July 29 with “Buy”. The stock has “Sell” rating by UBS on Thursday, December 15. The firm has “Strong Buy” rating by Needham given on Friday, April 28. As per Tuesday, November 8, the company rating was downgraded by Northcoast. The rating was maintained by RBC Capital Markets with “Outperform” on Monday, November 2.

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The company has market cap of $24.14 billion. The Company’s products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. It has a 48.57 P/E ratio. The Firm manages its activities through three geographic operating divisions: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets.